鸢尾素是一种新型能量代谢因子，血清水平随肾功能下降而降低。鸢尾素与多种代谢性疾病关系密切，可能与血液透析患者并发症及预后等有关。目前不能确定鸢尾素是否是血液透析患者的保护因素以及是否存在种族等群体差异。
risin is a new type of energy metabolism factor. Serum irisin level decreases along with the decline of renal function. Irisin is closely associated with a variety of metabolic diseases and probably with the complications and prognosis of hemodialysis patients. Whether or not serum irisin level has racial and population differences and irisin is a protective factor for hemodialysis patients are currently undetermined.
[1] Bostr?m P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis[J]. Nature. 2012 Jan 11;481(7382):463-8.? ?
[2] Zhang H, Wu X, Liang J, et al. Irisin, an exercise-induced bioactive peptide beneficial for health promotion during aging process[J]. Ageing Res Rev. 2022 Sep;80:101680.
[3] Perakakis N, Triantafyllou GA, Fernández-Real JM, et al. Physiology and role of irisin in glucose homeostasis[J]. Nat Rev Endocrinol. 2017 Jun;13(6):324-337.
[4] Farmer SR. Boning Up on Irisin[J]. N Engl J Med. 2019 Apr 11;380(15):1480-1482.
[5] Maak S, Norheim F, Drevon CA, et al. Progress and Challenges in the Biology of FNDC5 and Irisin[J]. Endocr Rev. 2021 Jul 16;42(4):436-456.?
[6] Bao JF, She QY, Hu PP, et al. Irisin, a fascinating field in our times[J]. Trends Endocrinol Metab. 2022 Sep;33(9):601-613.??
[7] Shen S, Liao Q, Chen X,et al. The role of irisin in metabolic flexibility: Beyond adipose tissue browning. Drug Discov Today[J]. 2022 Aug;27(8):2261-2267.
[8] Gan W, Chen W, Li T, et al. Circulating irisin level in chronic kidney disease patients: a systematic review and meta-analysis[J]. Int Urol Nephrol. 2022 Jun;54(6):1295-1302.? ?
[9] Wen MS, Wang CY, Lin SL, et al. Decrease in irisin in patients with chronic kidney disease[J]. PLoS One. 2013 May 7;8(5):e64025. ?
[10] Arcidiacono T, Magni G, Macrina L,et al. Serum Irisin May Predict Cardiovascular Events in Elderly Patients With Chronic Kidney Disease Stage 3-5[J]. J Ren Nutr. 2022 May;32(3):282-291.??
[11] Ebert T, Focke D, Petroff D,et al. Serum levels of the myokine irisin in relation to metabolic and renal function[J]. Eur J Endocrinol. 2014 Mar 8;170(4):501-6.?
[12] Rodríguez-Carmona A, Pérez Fontán M, Sangiao Alvarellos S, et al. Serum levels of the adipomyokine irisin in patients with chronic kidney disease[J]. Nefrologia. 2016 Sep-Oct;36(5):496-502. English, Spanish.
[13] Ka?u?na M, Pawlaczyk K, Schwermer K, et al. Adropin and irisin: New biomarkers of cardiac status in patients with end-stage renal disease? A preliminary study[J]. Adv Clin Exp Med. 2019 Mar;28(3):347-353.
[14] Csiky B, Sági B, Emmert V, et al. Cardiometabolic Effects of Irisin in Patients with End-Stage Renal Disease on Regular Hemo- or Peritoneal Dialysis[J]. Blood Purif. 2022;51(5):450-457.??
[15] 原成英,周晓霜,李荣山.终末期肾脏病患者血液透析前后血浆鸢尾素水平的变化[J].中华肾脏病杂志,2017,33(12):895-899.?
[16] Arcidiacono T, Macrina L, Premaschi S, et al. Serum concentrations of free indoxyl and p-cresyl sulfate are associated with mineral metabolism variables and cardiovascular risk in hemodialysis patients[J]. J Nephrol. 2022 Jun;35(5):1457-1465.?
[17] Lu CW, Wang CH, Lin YL, et al.Serum Irisin Level Is Positively Associated with Bone Mineral Density in Patients on Maintenance Hemodialysis[J]. Int J Endocrinol. 2021 Jan 25;2021:8890042.?
[18] 赵丹丹，戴仲方，孙嘉遥，等. 维持性血液透析患者血清鸢尾素水平与腰椎骨密度的相关性[J]. 中国血液净化, 2022, 21(11): 808-812.?
[19] Wang PW, Pang Q, Zhou T,et al. Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK/Drp1 signaling pathway in chronic kidney disease[J]. Atherosclerosis. 2022 Apr;346:36-45.?
[20] He L, He WY, A LT, et al. Lower Serum Irisin Levels Are Associated with Increased Vascular Calcification in Hemodialysis Patients[J]. Kidney Blood Press Res. 2018;43(1):287-295.
[21] He WY, Wu F, Pang XX, et al. Irisin is Associated with Urotensin II and Protein Energy Wasting in Hemodialysis Patients[J]. Kidney Blood Press Res. 2016;41(1):78-85.
[22] 宝群，闫燕，丁秀和. 维持性血液透析患者肌少症与同型半胱氨酸、鸢尾素及营养不良-炎症评分的关系[J]. 中国血液净化, 2022, 21(10): 744-748.?
[23] Mancinelli R, Checcaglini F, Coscia F,et al. Biological Aspects of Selected Myokines in Skeletal Muscle: Focus on Aging[J]. Int J Mol Sci. 2021 Aug 7;22(16):8520.
[24] Ho MY, Wang CY. Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy[J]. Cells. 2021 Aug 16;10(8):2103.
[25] Matsuo Y, Gleitsmann K, Mangner N, et al. Fibronectin type III domain containing 5 expression in skeletal muscle in chronic heart failure-relevance of inflammatory cytokines[J]. J Cachexia Sarcopenia Muscle. 2015 Mar;6(1):62-72.?
[26] Dong X, Fu W, Deng Y, et al. Lower serum irisin levels are associated with the increasing mortality of cardiovascular and cerebrovascular diseases in hemodialysis patients[J]. Ann Palliat Med. 2021 Jun;10(6):6052-6061.
[27] Chiang JM, Delgado C, Kaysen GA, et al. Correlates and Consequences of High Serum Irisin Concentration in Patients on Hemodialysis: A Longitudinal Analysis[J]. J Ren Nutr. 2021 Jul;31(4):389-396.
